- Home
- SNT vs SRZN Comparison
SNT vs SRZN Comparison
Compare SNT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- SRZN
- Stock Information
- Founded
- SNT 1965
- SRZN 2015
- Country
- SNT Canada
- SRZN United States
- Employees
- SNT N/A
- SRZN N/A
- Industry
- SNT Telecommunications Equipment
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- SNT Telecommunications
- SRZN Health Care
- Exchange
- SNT Nasdaq
- SRZN Nasdaq
- Market Cap
- SNT 74.4M
- SRZN 82.8M
- IPO Year
- SNT 1993
- SRZN N/A
- Fundamental
- Price
- SNT $3.46
- SRZN $10.03
- Analyst Decision
- SNT
- SRZN Strong Buy
- Analyst Count
- SNT 0
- SRZN 2
- Target Price
- SNT N/A
- SRZN $38.50
- AVG Volume (30 Days)
- SNT 20.3K
- SRZN 10.7K
- Earning Date
- SNT 04-23-2025
- SRZN 05-07-2025
- Dividend Yield
- SNT N/A
- SRZN N/A
- EPS Growth
- SNT N/A
- SRZN N/A
- EPS
- SNT 0.11
- SRZN N/A
- Revenue
- SNT $35,753,000.00
- SRZN $10,655,000.00
- Revenue This Year
- SNT N/A
- SRZN N/A
- Revenue Next Year
- SNT N/A
- SRZN N/A
- P/E Ratio
- SNT $31.64
- SRZN N/A
- Revenue Growth
- SNT 9.03
- SRZN N/A
- 52 Week Low
- SNT $1.27
- SRZN $6.00
- 52 Week High
- SNT $3.97
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- SNT 57.93
- SRZN 46.52
- Support Level
- SNT $2.95
- SRZN $9.57
- Resistance Level
- SNT $3.66
- SRZN $10.58
- Average True Range (ATR)
- SNT 0.19
- SRZN 0.59
- MACD
- SNT 0.05
- SRZN 0.07
- Stochastic Oscillator
- SNT 82.07
- SRZN 68.59
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).